
Managing PBM Trend in 2026: Your Need-to-Know Guide
Learn how your organization can stay ahead of the curve while managing costs and prioritizing member health.


Learn how your organization can stay ahead of the curve while managing costs and prioritizing member health.

A new formulation of lenacapavir has been developed for preexposure prophylaxis (PrEP) against HIV-1 infection. Yeztugo provides protection with only two annual injections. Gilead is also in the process of developing a once-yearly formulation of Yeztugo.

How ClearScript Partners With You to Improve Plan Performance, Not Just Measure It. At ClearScript, we’re proud to serve as more than just your pharmacy benefit manager. We’re your partner in navigating a complex and constantly evolving pharmacy landscape. And while robust reporting is a key part of our service, it’s only the beginning.

Putting Patients First: A Collaborative Approach to Managing Rheumatoid Arthritis and Reducing Costs.

ClearScript & Fairview Specialty Pharmacy’s Innovative Partnership Gain expert insight into Fairview and ClearScript’s approach to therapy management. Learn how…

ClearScript’s VP of Clinical & Account Services, Nicole Christian and Lynn Branch, PBM Client Commitments Director, break down how PBMs are evolving to support mental health care. Learn how your plan can improve access, affordability, and outcomes.

From tackling specialty drug costs to delivering member-focused solutions, Kyle breaks down what it really means to have a PBM in your corner.

What the FTC Reports Reveal—And Where ClearScript Stands The FTC’s interim reports on PBMs highlight a troubling trend: sky-high markups…

In this episode of Coffee with ClearScript, we’ll unpack how PBMs can help school districts lower costs, ensure transparency, meet regulatory requirements, and support complex union-driven benefit designs.

A well-aligned plan isn’t just cost-effective; it’s built with purpose, supporting your broader healthcare objectives and ensuring long-term impact.

Open enrollment can be a hectic season for HR teams and a confusing time for employees. But it’s also a…

YESINTEK (ustekinumab-kfce)Manufacturer: BioconLaunch Date: 2/24/2025 SELARSDI (ustekinumab-aekn)Manufacturer: Alvotech/TevaLaunch Date: 1/2025 YESINTEK & SELARSDI are biosimilars of reference product STELARA (Ustekinumab),…